identification of novel pathological regulators in this tissue. Oxidative stress is a fundamental pathological mediator; ROS generating enzyme NADPH oxidase (Nox enzyme) has attracted intense interest recently as it is the only enzyme that produces ROS as its sole function and can be targeted without compromising normal biochemical oxidation. Our recent pilot study provided initial evidence for the presence of such system in bladder urothelium and its potential functional significance. This study aimed firstly to define the importance of urothelial superoxide production in the body and secondly to dissect the enzymatic sources of superoxide production in the bladder.
INTRODUCTION AND OBJECTIVES:
Many studies focus on afferent or efferent inputs (but not both), or on one structure of the genitourinary system. Only a few studies include information on inputs from sympathetic chain ganglia (SCG), and even fewer have examined the possibility of direct motor (autonomic or somatic) inputs from spinal cord ventral horns to genitourinary end organs. We sought to clarify origins of afferent and efferent information conveyed between the spinal cord, peripheral nervous system ganglia and genitourinary structures using retrograde and anterograde neurotracing dyes.
METHODS: Dyes were injected into the bladder wall, external urethral sphincter (EUS) and clitoris of 14 female mongrel dogs (Fluorogold, True blue, or Nuclear Yellow). Dorsal root ganglia (DRG), SCG, caudal mesenteric ganglion (CMG), pelvic plexus ganglia and spinal cord ventral horns were examined for dye-labeled neuronal cell bodies. Detrusor muscle intramural ganglia were examined by injecting DiI into the pelvic nerve's anterior vesicle branch.
RESULTS: Retrograde labeled cells were observed in several DRGs, representative of afferent input from the bladder, EUS and clitoris (Table) . Anterograde labeling revealed intramural ganglia in the bladder wall. Sympathetic efferents included: 1) labeled cells in the CMG primarily from the bladder, yet small numbers from the EUS and clitoris; 2) labeled cells in SCG primarily from the bladder (widespread) and more localized input from EUS and clitoris (Table) ; and 3) labeled cells in the intermediolateral cell column of thoracolumbar cord segments directly to the bladder and clitoris, a locale typically considered as sympathetic. Parasympathetic efferents included: 1) labeled neurons in pelvic plexus ganglia in bladder mesenteries; and 2) cells in lamina VII of sacral cord segments directly to the bladder and clitoris, a locale typically considered as sympathetic. Lastly, somatic (skeletal muscle) efferents to the EUS were evident as retrogradely labeled cells in sacral lamina IX cells.
CONCLUSIONS: Afferent and efferent inputs to genitourinary structures are complex, yet a clear knowledge is needed to understand dysfunction after spinal cord injury and mechanisms underlying chronic pain syndromes in this region.
Source of Funding: NIH-NINDS NS070267

MP42-17 AGE RELATED URETHRAL SPHINCTER MUSCLE DYSFUNCTION AND FIBROSIS: POSSIBLE ROLE OF WNT SIGNALING PATHWAYS
M. Raj Rajasekaran*, Johnny Fu, My-Uyen (Lilly) Nguyen, Valmik Bhargava, San Diego, CA INTRODUCTION AND OBJECTIVES: Previous studies show an age-related increase in the prevalence of urinary incontinence (UI) (10-15% in adults and~30% % in older population >70 years). Agerelated degenerative changes to urethral sphincter muscles are recognized as the most common cause for UI in the geriatric population. Recently, Wntb catenin signaling pathway is recognized as the major molecular pathway involved in age-related skeletal muscle fibrosis. We tested the hypothesis that increased urethral sphincter fibrosis during advanced aging is mediated by a novel Wnt-b catenin signaling pathways.
METHODS: We used a rabbit model to establish time course of age-related urethral sphincter muscle complex dysfunction and for further evaluation of molecular mechanisms of muscle dysfunction /fibrosis in rabbits. We employed (n¼3) young (6-9 months), middle age (>12 months) and old rabbits (>30 months) and harvested mid-urethra (for rhabdosphincter) samples to evaluate protein and mRNA levels of markers of fibrosis using Western blot (protein) /qPCR (mRNA) studies respectively. RESULTS: Our rabbit studies confirmed age-related changes in alterations in closure pressure as well as in protein/mRNA levels of markers of fibrosis (b-catenin, collagen-I, and TGF-b etc; Fig A-C) . These observations confirm our hypothesis that age-related increase in fibrogenic proteins mediated via Wntb catenin signaling pathways may contribute to sphincter muscle dysfunction.
CONCLUSIONS: Our physiological and molecular studies are consistent with our hypothesis that age-related increase in fibrogenic proteins contribute to sphincter muscle function. Targeting Wnt signaling pathway may be beneficial in preventing sphincter muscle fibrosis. INTRODUCTION AND OBJECTIVES: Endocannabinoids exert potent analgesic and anti-inflammatory effects and may suppress clinical symptoms of painful inflammatory bladder diseases. 2-arachidonoyl glycerol (2-AG) is the most abundant endocannabinoid and the activity of 2-AG in the bladder has not been previously described. We investigated whether 2-AG has the potential to prevent visceral pain associated with experimental cystitis in mice.
METHODS: Expression of diacylglycerol lipase-a and -b (DAGL-a and -b, primary enzymes of 2-AG synthesis) and monoacylglycerol lipase (MAGL, primary enzyme of 2-AG degradation) in urothelium was examined by real-time RT-PCR and immunohistochemistry. Cystitis was induced by intraperitoneal injection of cyclophosphamide (CYP, 150 mg/kg), and mechanical sensitivity of hind paws was determined. Effects of 2-AG were also evaluated in cultured human urothelial cells.
RESULTS: DAGL-a, -b and MAGL were present in the mouse urothelium. CYP (3 hours) induced cystitis in mice characterized by submucosal edema. Pretreatment with a specific MAGL inhibitor JZL 184 (8 mg/kg/day, sc, 6 days) prior to CYP treatment did not appear to affect bladder inflammation. Mechanical sensitivity threshold was significantly reduced after CYP treatment in mice that received vehicle (basal: 2.9 AE 0.1 g; vehicle: 0.6 AE 0.1 g; n ¼6; p<0.01 vs basal). However, the increase of mechanical sensitivity was attenuated in JZL184-treated mice (basal: 2.8AE0.1 g; JZL 184: 1.4AE0.6 g; n ¼6, p<0.05 vs basal and vehicle-treated animals). CYP augmented expression of IL-6 mRNA in urothelium (151.8AE34.1 fold increase compared to control animals, n¼6, p<0.01 vs control) and JZL 184 inhibited increased IL-6 expression (79.5AE23.4, p<0.05 vs control and vehicle-treated animals). In cultured human urothelial cells, 2-AG attenuated LPS-induced increased TNF-a mRNA expression in a concentration-dependent manner.
CONCLUSIONS: We demonstrated the presence of the 2-AG pathway in the bladder, and this is the first available evidence that treatment with a MAGL inhibitor decreased visceral pain associated with cystitis. Urothelial cells play an important role in the activity of 2-AG in bladder. Manipulation of 2-AG may provide a novel therapeutic option for treatment of bladder pain. ] out ) co-related with the force development of contraction in human and pig urethral smooth muscle (USM). In addtion to this mechanism, the present study first revealed the distinctive temperature sensitivity of the tension force development of USM. Focusing on this temperature sensitivity of USM, the contribution of TRPV (Transient receptor potential vanilloid) channel was investigated. METHODS: The procedures described have been approved by ethical committee at Kyushu University hospital. Human USM was obtained from patients with bladder cancer undertaken radical cystectomy, while pig one from local abattoir. Isolated intact USM were dissected. Responses to warming-induced contraction (WIC) corresponding to [Ca 2+ ] out were investigated using isometric force recording. Various TRPV channel agonists and antagonists were examined.
RESULTS: The graded extracellular temperature change from 10 C to 37 C increased a sustained contraction (4.1 AE 0.7g, N¼6) in a temperature dependent manner in human and pig USM (fig, A, (fig, D) . Even in the presence of tetrodotoxin (1 mM) and prazosin (1 mM), these responses were also reproducible. TRPV1 agonists, capsaicin (up to 1 mM) or resiniferatoxin (10 mM) and accordingly, a TRPV4 agonist, GSK1016790A (1 mM) failed to induce pig USM contraction. A TRPV channel family antagonist, Ruthenium Red (100 mM) never inhibited WIC.
CONCLUSIONS: Extracellular Ca 2+ is essential for the generation of WIC, suggesting that the mechanism underlying WIC requires transmembrane Ca 2+ entry or intracellular Ca 2+ metabolic process. Though TRPV channel-related agents did not modulate USM contraction, it is strongly suggested that WIC results from TRPV channel activation. Subtype, splice-variant, or gene polymorphism of TRPV channel but not a typical one may be involved in WIC. This novel mechanism in urethra but not in detrusor might be a candidate for a treatment of lower urinary tract dysfunctions.
